VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
PRQR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
PRQRProQR Therapeutics N.V.
$1.64$172M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPRQRQuarterly Financials

ProQR Therapeutics N.V. (PRQR) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

ProQR Therapeutics N.V. (PRQR) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

PRQR Income Statement

Quarterly statement

PRQR Income Statement

ProQR Therapeutics N.V. (PRQR) annual income statement — 13-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue8.9M2.07M4.69M2.92M3.82M4.52M4.31M3.84M6.3M4.45M3.28M1.37M1.24M697K1.21M888K1.03M1.23M444K1.16M
Revenue Growth %133.27%-54.27%8.85%-24.15%-39.46%1.55%31.15%180.51%407.24%538.45%171.18%54.28%20.8%-43.38%172.75%-23.32%57.34%---
Cost of Goods Sold718.71K705.41K000000000000000000
COGS % of Revenue8.07%34.14%------------------
Gross Profit8.19M1.36M4.69M2.92M3.82M4.52M4.31M3.84M6.3M4.45M3.28M1.37M1.24M697K1.21M888K1.03M1.23M444K1.16M
Gross Margin %91.93%65.86%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %114.44%-69.88%8.85%-24.15%-39.46%1.55%31.15%180.51%407.24%538.45%171.18%54.28%20.8%-43.38%172.75%-23.32%57.34%---
Operating Expenses17.15M15.23M13.79M14.2M16.07M15.34M14.39M12.56M9.9M12.53M9.55M8.76M10.05M10.09M13.67M20.71M16.86M18.27M17.77M15.71M
OpEx % of Revenue192.65%737.24%294.05%487.1%420.91%339.35%334.06%326.8%157.1%281.46%290.86%639.49%808.85%1447.06%1128.9%2332.32%1638.58%1484.57%4002.7%1357.08%
Selling, General & Admin4.28M3.85M3.89M3.12M4.82M3.23M3.91M3.28M3.01M3.45M4.75M3.31M4.14M4.03M2.97M5.36M5.41M4.91M5.32M4.59M
SG&A % of Revenue48.03%186.41%83%107%126.17%71.56%90.85%85.43%47.79%77.57%144.64%241.97%333.47%577.62%245.42%603.49%525.95%398.7%1197.3%396.46%
Research & Development12.88M12.02M9.92M11.08M11.41M12.32M10.61M9.41M7.05M9.28M7.73M5.45M5.91M6.06M10.7M15.35M11.45M13.37M12.46M11.12M
R&D % of Revenue144.62%581.9%211.65%380.1%298.87%272.69%246.37%244.96%111.78%208.61%235.48%397.52%475.38%869.44%883.48%1728.83%1112.63%1085.87%2805.41%960.62%
Other Operating Expenses0-642.07K-28K0-158K-222K-136K-138K-156K-210K-1000K01000-1000
Operating Income-8.97M-13.87M-9.1M-11.28M-12.25M-10.82M-10.08M-8.72M-3.6M-8.07M-6.27M-7.39M-8.81M-9.39M-12.46M-19.82M-15.83M-17.04M-17.33M-14.56M
Operating Margin %-100.72%-671.37%-194.05%-387.1%-320.91%-239.34%-234.06%-226.8%-57.1%-181.46%-190.86%-539.49%-708.85%-1347.06%-1028.9%-2232.32%-1538.58%-1384.57%-3902.7%-1257.08%
Operating Income Growth %26.79%-28.27%9.76%-29.46%-240.25%-33.94%-60.83%-17.93%59.14%14%49.7%62.71%44.35%44.91%28.09%-36.18%-19.91%-40.82%-48.52%-34.02%
EBITDA-8.25M-13.17M-8.42M-10.61M-11.57M-10.14M-9.41M-8.03M-2.89M-7.38M-5.54M-6.75M-8.22M-8.84M-12.26M-19.21M-15.24M-16.47M-16.78M-14.01M
EBITDA Margin %-92.65%-637.24%-179.56%-364.08%-303.22%-224.34%-218.48%-208.9%-45.82%-165.93%-168.7%-492.63%-661.06%-1268.29%-1012.72%-2163.4%-1481.15%-1338.26%-3778.38%-1210.1%
EBITDA Growth %28.73%-29.89%10.54%-32.2%-300.62%-37.3%-69.86%-18.95%64.84%16.47%54.83%64.87%46.09%46.34%26.9%-37.09%-20.95%-43.6%-52.3%-37.23%
D&A (Non-Cash Add-back)718.71K705.41K679K671K675K678K671K688K711K691K728K642K594K549K196K612K591K570K552K544K
EBIT-8.97M-13.6M-6.89M-11.01M-12.16M-10.08M-6.49M-8.85M-2.89M-7.65M-1.02M-7.39M-8.81M-9.39M-12.46M-19.82M-15.83M-17.04M-17.33M-14.56M
Net Interest Income154.51K215.49K0327.21K192K455K704K469K513K488K1.1M363K470K-544K-1.23M599K1.16M-822K-909K266K
Interest Income154.51K215.49K0327.21K192K455K704K469K515.59K490.87K824.29K373.56K468.97K00599K1.16M0-890K266K
Interest Expense000000002.59K2.87K-276.71K10.56K-1.03K544K1.23M00822K19K0
Other Income/Expense120.97K270.37K178K278K88K737K776K608K708K420K790K2.01M876K534K-840K-3.41M2.37M2.93M-890K-477K
Pretax Income-8.85M-13.6M-8.92M-11.01M-12.16M-10.08M-9.3M-8.11M-2.89M-7.66M-5.48M-5.38M-7.94M-8.86M-13.3M-23.23M-13.46M-14.11M-18.22M-15.03M
Pretax Margin %-99.36%-658.29%-190.25%-377.56%-318.6%-223.04%-216.04%-210.98%-45.87%-172.02%-166.81%-392.63%-638.38%-1270.44%-1098.27%-2616.55%-1308.36%-1146.22%-4103.15%-1298.27%
Income Tax25.41K01K018K000-200K3K5K41K42K0069K20K7K22K35K
Effective Tax Rate %-0.29%0%-0.01%0%-0.15%0%0%0%6.92%-0.04%-0.09%-0.76%-0.53%0%0%-0.3%-0.15%-0.05%-0.12%-0.23%
Net Income-8.87M-13.6M-8.92M-11.01M-12.18M-10.08M-9.3M-8.11M-2.69M-7.66M-5.48M-5.71M-7.99M-8.93M-13.3M-23.32M-13.7M-14.11M-18.22M-15.05M
Net Margin %-99.65%-658.29%-190.27%-377.56%-319.07%-223.04%-216.04%-210.98%-42.7%-172.09%-166.96%-416.79%-643.04%-1281.64%-1098.02%-2625.9%-1331.39%-1146.14%-4103.83%-1299.4%
Net Income Growth %27.15%-34.96%4.14%-35.74%-352.41%-31.61%-69.71%-42%66.32%14.27%58.77%75.51%41.66%36.69%27.02%-54.97%12.99%-11.91%-37.86%-14.16%
Net Income (Continuing)-8.87M-13.6M-8.92M-11.01M-12.18M-10.08M-9.3M-8.11M-2.69M-7.66M-5.48M-5.42M-7.98M-8.86M-13.3M-23.3M-13.48M-14.12M-18.24M-15.07M
Discontinued Operations00000000000000000000
Minority Interest000000000000-290K-306K-384K-381K-395K-612K-604K-585K
EPS (Diluted)-0.08-0.13-0.09-0.10-0.12-0.10-0.11-0.10-0.03-0.09-0.07-0.07-0.10-0.10-0.14-0.34-0.21-0.20-0.26-0.22
EPS Growth %32.75%-30%22.64%-0.7%-263.64%-5.93%-61.53%-40.85%66.6%4.45%51.36%79.26%52.95%50.6%46.15%-54.55%12.5%20%0%15.38%
EPS (Basic)-0.08-0.13-0.09-0.10-0.12-0.10-0.11-0.10-0.03-0.09-0.07-0.07-0.10-0.10-0.14-0.34-0.21-0.20-0.26-0.22
Diluted Shares Outstanding109.96M105.36M103.01M110.06M105.34M105.3M81.67M81.67M81.67M81.57M78.46M81M80.94M80.89M77.39M71.38M71.36M71.36M71.24M68.26M
Basic Shares Outstanding109.96M105.36M103.01M105.35M105.34M105.3M81.67M81.67M81.67M81.57M78.46M81M80.94M80.89M77.39M71.38M71.36M71.36M71.24M68.26M
Dividend Payout Ratio--------------------